1.
|
Original article
|
Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes. 2024/02/27
|
2.
|
Original article
|
The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19. 2023/04
|
3.
|
Original article
|
Establishment and Characterization of an Acute Lymphocytic Leukemia Cell Line Expressing CD13 and CD33 with a Complex Philadelphia Translocation. 2023/03
|
4.
|
Original article
|
Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation. 2023/02
|
5.
|
Original article
|
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma. 2023/02
|
6.
|
Original article
|
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study. 2023/02
|
7.
|
Original article
|
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia. 2023/01
|
8.
|
Original article
|
Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma. 2023/01
|
9.
|
Original article
|
Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic Leukemia. 2022/12
|
10.
|
Original article
|
Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study. 2022/12
|
11.
|
Original article
|
Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program. 2022/10
|
12.
|
Original article
|
Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis. 2022/10
|
13.
|
Original article
|
Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation. 2022/09
|
14.
|
Original article
|
Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades. 2022/08
|
15.
|
Original article
|
Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation. 2022/08
|
16.
|
Original article
|
Skin lesions as the initial sign of systemic relapse in a case of Waldenström's macroglobulinemia. 2022/08
|
17.
|
Original article
|
Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission. 2022/06
|
18.
|
Original article
|
Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation. 2022/03
|
19.
|
Original article
|
Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission. 2022/03
|
20.
|
Original article
|
Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients. 2022/02
|
21.
|
Original article
|
Genetic alterations in patients with chronic leukocytosis and persistent thrombocytosis 2022/01/18
|
22.
|
Original article
|
A case of lung intravascular large B cell lymphoma developed with respiratory failure rescued by corticosteroid prior to definite diagnosis. 2022
|
23.
|
Original article
|
Genetic alterations in patients with chronic leucocytosis and persistent thrombocytosis. 2022
|
24.
|
Original article
|
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse. 2021/11
|
25.
|
Original article
|
Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT. 2021/11
|
26.
|
Original article
|
Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy. 2021/11
|
27.
|
Original article
|
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients. 2021/10
|
28.
|
Original article
|
High PRAME expression is associated with poor survival and early disease progression in myelodysplastic syndromes with a low bone marrow blast percentage. 2021/10
|
29.
|
Case report
|
Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports. 2021/09
|
30.
|
Original article
|
Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis. 2021/09
|
31.
|
Original article
|
Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program. 2021/08
|
32.
|
Review article
|
Recent advances in cellular therapy for malignant lymphoma. 2021/08
|
33.
|
Original article
|
Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia. 2021/06
|
34.
|
Original article
|
Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors. 2021/03
|
35.
|
Review article
|
Recent advances in chimeric antigen receptor natural killer cell therapy for overcoming intractable hematological malignancies. 2021/02
|
36.
|
Original article
|
Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2. 2021/01
|
37.
|
Original article
|
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study. 2020/12
|
38.
|
Original article
|
Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities. 2020/11
|
39.
|
Original article
|
Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities. 2020/11
|
40.
|
Review article
|
Recent progress in and challenges in cellular therapy using NK cells for hematological malignancies. 2020/11
|
41.
|
Original article
|
The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation. 2020/10
|
42.
|
Original article
|
Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. 2020/07
|
43.
|
Original article
|
Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia. 2020/07
|
44.
|
Original article
|
Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT. 2020/07
|
45.
|
Original article
|
Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients. 2020/04
|
46.
|
Original article
|
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma. 2020/04
|
47.
|
Original article
|
Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood Transplantation. 2020/03
|
48.
|
Case report
|
A case of lymphangioleiomyomatosis with diffuse large B-cell lymphoma: Usefulness of FDG-PET. 2020
|
49.
|
Original article
|
Different impact of BCR-ABL transcripts on allogeneic hematopoietic cell transplantation from different graft sources for Ph + ALL with minimal residual disease. 2019/11
|
50.
|
Original article
|
Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-matched Allogeneic Transplantation: A Japanese National Registry Study. 2019/11
|
51.
|
Original article
|
Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes. 2019/11
|
52.
|
Original article
|
Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance(MGRS) 2019/10/17
|
53.
|
Original article
|
Expression analysis of genes located within the common deleted region of del(20q) in patients with myelodysplastic syndromes. 2019/09
|
54.
|
Original article
|
Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group. 2019/09
|
55.
|
Original article
|
Herpes zoster after autologous haematopoietic stem cell transplantation without antiviral prophylaxis. 2019/09
|
56.
|
Original article
|
Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2019/09
|
57.
|
Original article
|
A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphoma. 2019/08
|
58.
|
Original article
|
Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults. 2019/08
|
59.
|
Original article
|
The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese Society of Hematology Blood Disease Registry. 2019/08
|
60.
|
Original article
|
Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. 2019/07
|
61.
|
Original article
|
The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation. 2019/07
|
62.
|
Original article
|
Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma. 2019/06
|
63.
|
Original article
|
Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission. 2019/05
|
64.
|
Original article
|
Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades. 2019/04
|
65.
|
Original article
|
Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era. 2018/10
|
66.
|
Original article
|
Clinical impact of serum soluble SLAMF7 in multiple myeloma. 2018/10
|
67.
|
Original article
|
Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. 2018/04
|
68.
|
Original article
|
Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation. 2018/04
|
69.
|
Original article
|
Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan. 2018/02
|
70.
|
Original article
|
Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults. 2018/01
|
71.
|
Original article
|
Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey. 2017/12
|
72.
|
Original article
|
Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy. 2017/10
|
73.
|
Original article
|
Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia. 2017/09
|
74.
|
Original article
|
Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myelogenous Leukemia. 2017/09
|
75.
|
Original article
|
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Abnormalities of the Short Arm of Chromosome 17. 2017/08
|
76.
|
Original article
|
Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults. 2017/07
|
77.
|
Original article
|
Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2017/06
|
78.
|
Original article
|
Tumor suppressor gene methylation on the short arm of chromosome 1 in chronic myelogenous leukemia. 2017/05
|
79.
|
Original article
|
Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. 2017/01
|
80.
|
Original article
|
Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia. 2016/12
|
81.
|
Original article
|
High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study. 2016/12
|
82.
|
Review article
|
Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies. 2016/11
|
83.
|
Original article
|
Translocation (9;12)(q34.1;p13.?3) Resulted in ETV6-ABL1 Fusion in a Patient with Philadelphia Chromosome-Negative Chronic Myelogenous Leukemia. 2016/11
|
84.
|
Case report
|
Acquired hemophilia A associated with myasthenia gravis and Isaacs' syndrome 2016/10
|
85.
|
Case report
|
Successful Treatment of Ascites using a Denver Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome 2016/10
|
86.
|
Original article
|
Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine. 2016/09
|
87.
|
Original article
|
Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era. 2016/09
|
88.
|
Original article
|
Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR. 2016/05
|
89.
|
Original article
|
Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma. 2016/04
|
90.
|
Original article
|
Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study. 2016/03
|
91.
|
Original article
|
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. 2016/02
|
92.
|
Original article
|
Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT. 2016/01
|
93.
|
Original article
|
Outcomes of allogeneic hematopoietic cell transplantation in patients with biphenotypic acute leukemia. 2016/01
|
94.
|
Original article
|
Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration. 2015/12
|
95.
|
Original article
|
Identification of the SOX5 gene as a novel IGH-involved translocation partner in BCL2-negative follicular lymphoma with t(12;14)(p12.2;q32). 2015/11
|
96.
|
Original article
|
Conditioning Regimen in Allogeneic Transplantation for Elderly Patients with Advanced Myelodysplastic Syndromes 2015/02
|
97.
|
Original article
|
Decision Analysis for Donor 1 Selection in Stem Cell Transplantation -2 HLA-8/8 Allele-Matched Unrelated Donor vs. HLA-1 AG Mismatched Related Donor 2014/12
|
98.
|
Original article
|
Analysis of outcomes following autologous transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia during the first complete remission 2014/11
|
99.
|
Original article
|
Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A retrospective analysis by the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation 2014/11
|
100.
|
Original article
|
Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection 2014/10
|
101.
|
Original article
|
Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study 2014/06
|
102.
|
Original article
|
Bone Marrow Graft-versus-Host Disease: Evaluation of Its Clinical Impact on Disrupted Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplantation. 2014/04
|
103.
|
Original article
|
Pre-transplant administration of imatinib for allogeneic hematopoietic stem cell transplantation in patients with BCR-ABL-positive acute lymphoblastic leukemia 2014/04
|
104.
|
Original article
|
Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT. 2014/02
|
105.
|
Original article
|
Epstein-barr virus-associated smooth muscle tumors after bone marrow transplantation. 2014/01
|
106.
|
Original article
|
Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available? 2013/11
|
107.
|
Original article
|
Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission. 2013/11
|
108.
|
Original article
|
L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma. 2013/11
|
109.
|
Original article
|
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2013/11
|
110.
|
Original article
|
Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). 2013/11
|
111.
|
Original article
|
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia. 2013/09
|
112.
|
Original article
|
A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group. 2013/08
|
113.
|
Original article
|
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. 2013/06
|
114.
|
Original article
|
Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation. 2013/05
|
115.
|
Original article
|
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. 2013/04
|
Display 5 items
|
Display all(115)
|